The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for OriGen Biomedical sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
OriGen Biomedical Inc (OriGen Biomedical) is a medical equipment provider that manufactures, distributes, and markets cardiac care and cell culture devices. The company’s products include ECMO respiratory and cell culture, and cryopreservation devices. Its cryopreservation products include cryostore conical freezing bag, O-wrap bags, cryostore freezing bag, sterizip overpouch, cryopur DMSO, tissue vault, and tube sealer, cryobag, accessory sets, DMSO resistant stopcock, and cell connect, among others. OriGen Biomedical’s cell culture products comprise evolve cell culture bags, perm life cell culture bags and accessory sets, among others. The company has operation in Germany and the US. OriGen Biomedical is headquartered in Austin, Texas, the US. Key subsidiaries of OriGen Biomedical include OriGen Biomedical.
The key metrics of OriGen Biomedical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As OriGen Biomedical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as OriGen Biomedical.
For a detailed understanding of the performance of OriGen Biomedical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
